サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1460666

機能ゲノミクス市場- 世界の産業規模、シェア、動向、機会、予測、製品別、技術別、用途別、エンドユーザー別、地域別、競合、2019～2029年

Functional Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2019-2029F
出版日: | 発行: TechSci Research | ページ情報: 英文 180 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

機能ゲノミクス市場- 世界の産業規模、シェア、動向、機会、予測、製品別、技術別、用途別、エンドユーザー別、地域別、競合、2019～2029年
出版日: 2024年04月03日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の機能ゲノミクス市場は、2023年に95億4,000万米ドルと評価され、2029年のCAGRは9.25%で、予測期間中に力強い成長が予測されています。

世界の機能ゲノミクス市場は、遺伝子研究と個別化医療の進歩が需要の増加を促進し、力強い成長を遂げています。機能ゲノミクスは、生物内の遺伝子の機能と相互作用を系統的に研究するもので、病気の根本的なメカニズムに関する貴重な洞察を記載しています。この市場の拡大には、遺伝性疾患、がん、感染症の有病率の上昇が研究開発活動の急増を促していることが寄与しています。CRISPR-Cas9、RNA干渉、次世代シーケンシングなどの主要技術は、精密な遺伝子編集や遺伝子発現パターンの包括的解析を容易にし、機能ゲノミクス研究において極めて重要な役割を果たしています。製薬会社やバイオテクノロジー企業はこの市場に大きく貢献しており、新規創薬標的の発見や個別化治療介入の開発のために革新的技術に投資しています。さらに、人工知能とビッグデータ解析の統合は、機能ゲノミクス研究の効率をさらに高める。精密医療を重視する傾向が強まる中、世界の機能ゲノミクス市場は、様々な遺伝的疾患の理解、診断、治療におけるブレークスルーが期待され、継続的な拡大が見込まれています。ゲノミクスは分子生物学の一セグメントであり、生物の全遺伝子とその機能を含むDNA一式の研究に焦点を当てています。生物の完全な遺伝物質であるゲノムの構造、機能、組織を分析します。ゲノミクスでは、科学者はさまざまな技術や手法を駆使して、生物のDNA配列全体の塩基配列を決定し、組み立て、解析します。これには、DNA分子を構成するヌクレオチド（アデニン、チミン、シトシン、グアニン）の順序を決定することも含まれます。ゲノムを研究することによって、研究者は生物内にコードされた遺伝情報を理解することを目的としています。機能ゲノミクスは、遺伝子の機能と活性、生物学的システム内での相互作用を理解することを目的としています。遺伝子発現、タンパク質機能、遺伝子活性を制御する制御ネットワークの研究が含まれます。機能ゲノミクスは、遺伝子配列決定と解析の進歩を活用し、個人の遺伝子データに基づいて機能的な物語、キャラクター、世界を作り出します。個人の遺伝コードを調べることで、様々なアルゴリズムや機械学習技術が採用され、特定の遺伝的特徴、素質、特性が特定されます。この情報は、パーソナライズされた物語や機能的なシナリオを作成するために使用されます。

市場の促進要因

技術的進歩に対する需要の高まり

データ分析とバイオインフォマティクスに対する意識の高まり

データ可視化とデータ解釈への関心の高まり

主要市場課題

データのプライバシーとセキュリティ

生体システムの複雑性

主要市場動向

CRISPR技術の進歩

オミックス技術の統合

セグメント別洞察

製品別洞察

技術別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の機能ゲノミクス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別（キットアッセイ、機器）
    • 技術別（次世代シーケンサー（NGS）、ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、その他技術）
    • 用途別（エピゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクス）
    • エンドユーザー別（学術・研究機関、バイオテクノロジー・バイオ医薬品企業、その他のエンドユーザー（病院、クリニック、診断ラボ））
    • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
    • 企業別（2023年）
  • 市場マップ
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 地域別

第6章 北米の機能ゲノミクス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の機能ゲノミクス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州：国別分析
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の機能ゲノミクス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア

第9章 南米の機能ゲノミクス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの機能ゲノミクス市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 中東・アフリカ：国別分析
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と新興国市場の開拓

第13章 競合情勢

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation（Integrated DNA Technologies, Inc.）
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • MRM Proteomics Inc
  • Perkin Elmer, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.

第14章 戦略的提言

第15章 当社について免責事項

目次
Product Code: 17125

Global Functional Genomics Market was valued at USD 9.54 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 9.25% through 2029. The Global Functional Genomics Market is experiencing robust growth as advancements in genetic research and personalized medicine drive increased demand. Functional genomics involves the systematic study of gene functions and interactions within an organism, providing valuable insights into the underlying mechanisms of diseases. This market's expansion is fueled by the rising prevalence of genetic disorders, cancer, and infectious diseases, prompting a surge in research and development activities. Key technologies such as CRISPR-Cas9, RNA interference, and next-generation sequencing play pivotal roles in functional genomics studies, facilitating precise gene editing and comprehensive analysis of gene expression patterns. Pharmaceutical and biotechnology companies are major contributors to this market, investing in innovative technologies to discover novel drug targets and develop personalized therapeutic interventions. Moreover, the integration of artificial intelligence and big data analytics further enhances the efficiency of functional genomics research. With a growing emphasis on precision medicine, the Global Functional Genomics Market is poised for continued expansion, promising breakthroughs in understanding, diagnosing, and treating various genetic conditions. Genomics is a branch of molecular biology that focuses on the study of an organism's complete set of DNAs, including all of its genes and their functions. It involves analyzing the structure, function, and organization of genomes, which are the complete genetic material of an organism. In genomics, scientists use various techniques and technologies to sequence, assemble, and analyze the entire DNA sequence of an organism. This includes determining the order of nucleotides (adenine, thymine, cytosine, and guanine) that make up the DNA molecule. By studying the genome, researchers aim to understand the genetic information encoded within an organism. The functional genomics aims to understand the function and activity of genes and their interactions within biological systems. It involves studying gene expression, protein function, and the regulatory networks that control gene activity. Functional genomics leverages advances in genetic sequencing and analysis to generate functional stories, characters, and worlds based on individuals' genetic data. By examining an individual's genetic code, various algorithms and machine learning techniques are employed to identify specific genetic traits, predispositions, and characteristics. This information is then used to craft personalized narratives or functional scenarios that are unique to everyone.

Key Market Drivers

Rising Demand for Technological Advancements

The rapid evolution of genomic sequencing technologies, notably next-generation sequencing (NGS), has revolutionized genomic analysis by enhancing speed, accuracy, and cost-effectiveness. These advancements have democratized functional genomics, catalyzing increased adoption and expansion of the global market. They have bolstered research capabilities, improved genomic analysis efficiency, and spurred the development of innovative tools and methodologies.Technologies such as microscopy, NGS platforms, and high-throughput screening have transformed genomic sequencing. NGS platforms offer heightened throughput, quicker turnaround times, enhanced precision, and reduced costs compared to conventional methods. This accessibility has enabled large-scale genomic sequencing, fostering broader acceptance of functional genomics research. These methods allow simultaneous analysis of numerous genetic interactions or gene expression patterns, facilitating rapid gene or genomic feature identification relevant to specific biological processes, diseases, or drug responses. High-throughput screening expedites functional genomics research and aids in uncovering novel therapeutic targets.Moreover, recent technological strides in single-cell genomics have revolutionized comprehension of cellular heterogeneity and biological system complexity. Single-cell sequencing technologies facilitate individual cell genomic profiling, offering insights into cell types, developmental processes, disease mechanisms, and gene expression dynamics at a granular level. These advancements have expanded functional genomics' scope, opening new research avenues in developmental biology, immunology, and oncology.In cancer genomics, precision medicine benefits from molecularly defined cancer types and subtypes. This molecular taxonomy enables precise diagnosis and personalized treatment strategies. For example, breast cancer classification based on molecular characteristics-such as Luminal A, Luminal B, Triple-negative/basal-like, and HER2 type-guides treatment decisions tailored to each subtype's aggressiveness and therapy responsiveness. Similarly, genomic profiling subdivides diffuse large B cell lymphoma into ABC and GCB subtypes, aiding in tailoring chemotherapy and targeted therapies. Consequently, these advancements are poised to drive further growth in the functional genomics market.

Growing Awareness for Data Analytics and Bioinformatics

The growth of the global functional genomics market is expected to be propelled by the integration of big data analytics and bioinformatics. As functional genomics generates vast and intricate genomic data sets, these fields offer essential tools and methodologies for analyzing, interpreting, and deriving actionable insights from such data.

Functional genomics produces large-scale genomic datasets that necessitate efficient management and integration. Big data analytics and bioinformatics provide the requisite tools and infrastructure to handle and process these extensive data volumes. They facilitate the storage, retrieval, and integration of genomic data from various sources, enabling researchers to access and analyze diverse datasets for comprehensive functional genomics studies.For example, the successful completion of the Human Genome Project by the National Human Genome Research Institute (NHGRI) marked a significant scientific milestone. This effort unveiled the complete sequence of chemical bases-As, Cs, Gs, and Ts-in the human genome. The project revealed that each human cell contains a complete set of genetic instructions encoded in DNA, with most cells housing two copies of this genome, totaling approximately 6 billion DNA letters.Today, researchers face an unprecedented influx of genomic data aimed at unraveling the genome's complexities and its implications for human health and disease. This wealth of data originates from diverse global populations, involving millions of individuals. To illustrate, a single human genome sequence generates data requiring 200 gigabytes of storage space, equivalent to roughly 200 copies of the film "Jaws." The anticipated accumulation of 40 exabytes to store worldwide genome sequence data is expected to drive the expansion of the global functional genomics market.Moreover, analyzing genomic data requires specialized computational tools to decipher biological insights within DNA and manage the resulting data volumes. Researchers utilize advanced software tools, such as aligners, to identify the precise locations of individual DNA segments within a reference genome sequence.The pursuit of genomic insights necessitates substantial financial support, with institutions like the NHGRI allocating over USD 125 million annually to various genomic data science initiatives. This ongoing investment is poised to propel the growth trajectory of the global functional genomics market.

Growing Interest in Data Visualization and Data Interpretation

The computational tool offers visualization techniques that empower researchers to explore and interpret genomic data effectively. These visualizations assist in recognizing patterns, trends, and relationships within the data, simplifying the communication and comprehension of intricate genomic information. By improving the comprehension of functional genomics data, visualization tools facilitate the dissemination of research findings to a broader audience.According to the National Institute of Health's National Center for Biotechnology Information, visualizing genomic data is a common practice in biomedical research. It aids in contextualizing knowledge within a genomic framework, streamlining communication, and facilitating dataset exploration for hypothesis generation. As biomedical research becomes increasingly data-driven and many studies lack well-defined hypotheses, a significant challenge lies in uncovering unexpected patterns and formulating unbiased questions amidst vast amounts of genomic and related data.

Moreover, visualization techniques assist in identifying potential biomarkers and molecular signatures associated with specific diseases or conditions. By visualizing genomic data, researchers can pinpoint gene expression patterns, genomic alterations, and regulatory networks characteristic of a particular disease phenotype. Visualization facilitates the discovery of potential diagnostic or prognostic biomarkers, driving the development of diagnostic tests and personalized treatment strategies. Often, this involves integrating various genomics data types, including genomics, transcriptomics, proteomics, and metabolomics. Integrated visualization aids in uncovering molecular interactions, pathways, and functional relationships, offering a comprehensive understanding of complex biological systems and potentially contributing to the growth of the global functional genomics market.

Key Market Challenges

Data Privacy and Security

Data privacy and security represent critical concerns within the Global Functional Genomics Market due to the sensitive nature of genomic information. With advancements such as CRISPR-Cas9 and next-generation sequencing, substantial volumes of genomic data are generated, containing individual genetic codes and their variations. Safeguarding this information is essential to uphold public trust and adhere to ethical standards.Genomic data often includes personally identifiable information, posing significant risks if not adequately protected. One major challenge is establishing robust frameworks to prevent unauthorized access, breaches, or misuse of genomic data. Potential misuse raises concerns about discrimination, stigmatization, or unauthorized profiling based on genetic makeup.Balancing data sharing for research with individual privacy protection is a delicate task, particularly in cross-border genomics research requiring international collaboration. Establishing global standards for data privacy and security is imperative, alongside harmonizing regulations and ensuring adherence to ethical guidelines.Advancements in encryption technologies and secure data-sharing platforms are pivotal in addressing these concerns. Implementing strong access controls, encryption protocols, and anonymization techniques helps mitigate the risk of data breaches.

Furthermore, promoting awareness and education on data privacy and security within the scientific community is crucial for fostering responsible data handling practices. Collaboration among researchers, industry stakeholders, and policymakers is essential for formulating and implementing comprehensive data protection policies.Establishing transparent consent mechanisms to inform individuals about the use and sharing of their genomic data is vital for maintaining ethical standards. By confronting data privacy and security challenges proactively, the Global Functional Genomics Market can cultivate trust and credibility, facilitating ongoing innovation while respecting individual rights and privacy.

Complexity of Biological Systems

The Global Functional Genomics Market contends with the intricate complexity inherent in biological systems, posing a significant challenge to researchers and scientists. Biological organisms operate within elaborate networks of genes, proteins, and molecular components, where understanding dynamic interactions is pivotal for meaningful insights. This complexity stems from multifaceted biological processes, encompassing gene regulation, signal transduction, and cellular responses to environmental stimuli.In functional genomics research, unraveling the complexities of biological systems is imperative for grasping the functions of individual genes and their roles in disease mechanisms. Interactions among genes, the impact of epigenetic modifications, and the dynamic nature of cellular processes contribute to the intricate puzzle researchers seek to solve. Furthermore, variability observed among individuals adds complexity, making generalization across diverse populations challenging.Technological advancements such as CRISPR-Cas9 and advanced sequencing methods have enhanced the ability to manipulate and analyze genes, yet interpreting resulting data comprehensively remains a challenge. The high-throughput nature of these technologies generates vast datasets, necessitating sophisticated bioinformatics tools for analysis and integration. Researchers must discern meaningful patterns amidst noise and comprehend the context-dependent nature of gene function within biological systems.Moreover, the interplay between genetic factors and environmental influences introduces another layer of complexity. Functional genomics research endeavors to elucidate how genetic variations interact with environmental factors to contribute to disease development. Addressing this complexity demands interdisciplinary collaboration, uniting molecular biologists, bioinformaticians, and systems biologists to integrate diverse datasets and perspectives.Despite these challenges, comprehending the complexity of biological systems is essential for advancing precision medicine and developing targeted therapies. As the Global Functional Genomics Market advances, tackling the intricacies of biological systems remains a focal point, driving innovation and expanding our understanding of genomics and its applications in healthcare and beyond.

Key Market Trends

Advancements in CRISPR Technology

Advancements in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology have been pivotal in shaping the Global Functional Genomics Market. Specifically, CRISPR-Cas9 enables precise and efficient gene editing, empowering researchers to selectively modify or manipulate specific DNA sequences within the genome. This technology has become integral to functional genomics studies, facilitating the exploration of gene functions, regulatory pathways, and their implications in various biological processes.One notable advancement is the expansion of CRISPR-based techniques beyond traditional gene knockout. Innovations like CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) enable researchers to modulate gene expression levels without permanently altering the DNA sequence. This diversified toolkit provides increased flexibility in studying gene functions and regulatory mechanisms.Moreover, improvements in CRISPR technology have enhanced precision and specificity, minimizing off-target effects and enhancing the overall safety and accuracy of gene editing. Innovations such as base editing and prime editing offer even finer control over genetic modifications, enabling the correction of single nucleotide changes without inducing double-strand breaks.In the Global Functional Genomics Market, the widespread adoption of CRISPR technology has expedited research in areas such as drug discovery, functional genomics screening, and therapeutic interventions. The ability to manipulate genes with precision has opened new avenues for comprehending the molecular underpinnings of diseases and identifying potential therapeutic targets.As CRISPR technology continues to advance, its applications in functional genomics are poised to catalyze further breakthroughs, shaping the future of genomic research and its diverse applications in medicine, agriculture, and beyond.

Integration of Omics Technologies

The Integration of Omics Technologies has emerged as a pivotal trend in the Global Functional Genomics Market, transforming the breadth and depth of genomic research. Omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, enable comprehensive analysis of biological molecules. By integrating these multi-omics approaches, researchers gain a holistic understanding of gene functions, regulatory networks, and the intricate interactions among biological components within cellular systems.Genomics, exploring complete DNA sequences, is complemented by transcriptomics, which examines gene expression patterns. Proteomics delves into the entire set of proteins in a cell, while metabolomics analyzes small molecule metabolites. Integrating these datasets enables researchers to unveil complex relationships between genes, proteins, and metabolic pathways. This comprehensive perspective is crucial for deciphering disease mechanisms and identifying potential therapeutic targets.The integration of omics technologies is particularly valuable in functional genomics research, where scientists seek to elucidate gene functions and their roles in cellular processes. By merging genomic data with insights into gene expression, protein levels, and metabolite profiles, researchers can construct more holistic models of cellular functions and disease mechanisms. This trend promotes a systems biology approach, analyzing biological systems as a whole rather than individual components.Insights gleaned from integrated omics studies find applications in personalized medicine, drug discovery, and targeted therapy development. As the Global Functional Genomics Market advances, the integration of omics technologies is expected to remain a driving force, fueling advancements that deepen our understanding of biological system complexity and pave the way for novel therapeutic strategies.

Segmental Insights

Product Insights

Based onproduct,kits assays segment dominated the Global Functional Genomics Market in 2023.This is ascribed due to its convenience, cost-effectiveness, and user-friendly nature. These ready-to-use kits and assays streamline complex laboratory processes, making functional genomics research accessible to a broader range of scientists. The pre-packaged nature of these products reduces the need for specialized expertise, accelerates experimental timelines, and ensures consistent results. Additionally, the market's growth is fueled by the increasing demand for high-throughput screening and the widespread adoption of functional genomics techniques in diverse research areas, including drug discovery, diagnostics, and personalized medicine.

Technology Insights

Based on technology, Next-Generation Sequencing (NGS) segment dominated the Global Functional Genomics Market in 2023. This is ascribed due to its unparalleled efficiency in rapidly and cost-effectively sequencing large volumes of genetic material. NGS enables simultaneous analysis of multiple genes, whole genomes, or entire transcriptomes, providing comprehensive insights into genetic variations and gene expression. Its high throughput, scalability, and ability to uncover complex genetic information make it indispensable in functional genomics research, personalized medicine, and clinical diagnostics. The continuous technological advancements, reduced sequencing costs, and diverse applications contribute to NGS maintaining its dominant position in the evolving landscape of genomic technologies.

Regional Insights

North America dominates the Global Functional Genomics Market due to a confluence of factors. The region has a robust research infrastructure, extensive funding for genomics research, and a high concentration of leading biotechnology and pharmaceutical companies. Additionally, supportive government initiatives, a skilled workforce, and collaborations between academia and industry contribute to North America's leadership. Access to advanced technologies, such as CRISPR-Cas9, and a favorable regulatory environment further propel the region's dominance in functional genomics, making it a focal point for cutting-edge research and innovation in the field.

Key Market Players

Agilent Technologies, Inc.

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc.

Danaher Corporation (Integrated DNA Technologies, Inc.)

F. Hoffmann-La Roche Ltd.

Illumina, Inc.

MRM Proteomics Inc

Perkin Elmer, Inc.

QIAGEN N.V.

--Thermo Fisher Scientific, Inc.

Report Scope:

In this report, the Global Functional Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Functional Genomics Market,By Product:

  • Kits Assays
  • Instruments

Functional Genomics Market,By Technology:

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Other Technologies

Functional Genomics Market,By Application:

  • Epigenomics
  • Transcriptomics
  • Proteomics
  • Metabolomics

Functional Genomics Market,By End-User:

  • Academic and Research Institutions
  • Biotechnology and Biopharmaceutical Companies
  • Others

Functional Genomics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Functional Genomics Market.

Available Customizations:

Global Functional Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2.Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation Validation
  • 2.7. Assumptions and Limitations

3.Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Functional Genomics Market Outlook

  • 5.1. Market Size Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Forecast
    • 5.2.1. By Product (Kits Assays, Instruments)
    • 5.2.2. By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Other Technologies)
    • 5.2.3. By Application (Epigenomics, Transcriptomics, Proteomics, Metabolomics)
    • 5.2.4. By End User (Academic and Research Institutions, Biotechnology and Biopharmaceutical Companies, Other End Users (Hospitals, Clinics, and Diagnostic Labs)
    • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle-East and Africa)
    • 5.2.6. By Company (2023)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Technology
    • 5.3.3. By Application
    • 5.3.4. By End User
    • 5.3.5. By Region

6.North America Functional Genomics Market Outlook

  • 6.1. Market Size Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3.North America: Country Analysis
    • 6.3.1.United States Functional Genomics Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2.Canada Functional Genomics Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3.Mexico Functional Genomics Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7.Europe Functional Genomics Market Outlook

  • 7.1. Market Size Forecast
    • 7.1.1. By Value
  • 7.2. Market Share Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3.Europe: Country Analysis
    • 7.3.1.Germany Functional Genomics Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2.France Functional Genomics Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3.United Kingdom Functional Genomics Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4.Italy Functional Genomics Market Outlook
      • 7.3.4.1.Market Size Forecast
        • 7.3.4.1.1.By Value
      • 7.3.4.2.Market Share Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5.Spain Functional Genomics Market Outlook
      • 7.3.5.1.Market Size Forecast
        • 7.3.5.1.1.By Value
      • 7.3.5.2.Market Share Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8.Asia-Pacific Functional Genomics Market Outlook

  • 8.1. Market Size Forecast
    • 8.1.1. By Value
  • 8.2. Market Share Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3.Asia-Pacific: Country Analysis
    • 8.3.1.China Functional Genomics Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2.Japan Functional Genomics Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3.India Functional Genomics Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4.South Korea Functional Genomics Market Outlook
      • 8.3.4.1.Market Size Forecast
        • 8.3.4.1.1.By Value
      • 8.3.4.2.Market Share Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5.Australia Functional Genomics Market Outlook
      • 8.3.5.1.Market Size Forecast
        • 8.3.5.1.1.By Value
      • 8.3.5.2.Market Share Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9.South America Functional Genomics Market Outlook

  • 9.1. Market Size Forecast
    • 9.1.1. By Value
  • 9.2. Market Share Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3.South America: Country Analysis
    • 9.3.1.Brazil Functional Genomics Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2.Argentina Functional Genomics Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3.Colombia Functional Genomics Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10.Middle East and Africa Functional Genomics Market Outlook

  • 10.1. Market Size Forecast
    • 10.1.1. By Value
  • 10.2. Market Share Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3.MEA: Country Analysis
    • 10.3.1.UAE Functional Genomics Market Outlook
      • 10.3.1.1.Market Size Forecast
        • 10.3.1.1.1.By Value
      • 10.3.1.2.Market Share Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2.Saudi Arabia Functional Genomics Market Outlook
      • 10.3.2.1.Market Size Forecast
        • 10.3.2.1.1.By Value
      • 10.3.2.2.Market Share Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3.South Africa Functional Genomics Market Outlook
      • 10.3.3.1.Market Size Forecast
        • 10.3.3.1.1.By Value
      • 10.3.3.2.Market Share Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11.Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12.Market Trends Developments

13.Competitive Landscape

  • 13.1. Agilent Technologies, Inc.
    • 13.1.1. Business Overview
    • 13.1.2. Product Offerings
    • 13.1.3. Recent Developments
    • 13.1.4. Financials (In Case of Listed Companies)
    • 13.1.5. Key Personnel
  • 13.2. Becton, Dickinson and Company
  • 13.3. Bio-Rad Laboratories, Inc.
  • 13.4. Danaher Corporation (Integrated DNA Technologies, Inc.)
  • 13.5.F. Hoffmann-La Roche Ltd.
  • 13.6.Illumina, Inc.
  • 13.7. MRM Proteomics Inc
  • 13.8. Perkin Elmer, Inc.
  • 13.9. QIAGEN N.V.
  • 13.10. Thermo Fisher Scientific, Inc.

14.Strategic Recommendations

15. About Us Disclaimer